About AccurKardia
AccurKardia is a company based in New York (United States) founded in 2019 by Tony M Kuttiachen, Juan C Jimenez, Mohamed Sadeq Ali, John Fox, and Naveen Srinivas.. AccurKardia has raised $6.81 million across 2 funding rounds from investors including Banco Popular. AccurKardia offers products and services including AccurECG, AK-AVS, and AK+ Guard. AccurKardia operates in a competitive market with competitors including Endotronix, Edwards Lifesciences, CoachCare, BioIntelliSense and Element Science, among others.
- Headquarter New York, United States
- Founders Tony M Kuttiachen, Juan C Jimenez, Mohamed Sadeq Ali, John Fox, Naveen Srinivas
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Accurkardia, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.81 M (USD)
in 2 rounds
-
Latest Funding Round
$4.11 M (USD), Series A
Jun 30, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AccurKardia
AccurKardia offers a comprehensive portfolio of products and services, including AccurECG, AK-AVS, and AK+ Guard. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automates ECG analysis for streamlined diagnostics in healthcare settings.
Supports detection of conditions through ECG for investigational use only.
Aids in managing health conditions via ECG signals under development.
Unlock access to complete
Unlock access to complete
Funding Insights of AccurKardia
AccurKardia has successfully raised a total of $6.81M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.11 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $4.1M
-
First Round
First Round
(20 Jun 2023)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Series A - AccurKardia | Valuation |
investors |
|
| Jun, 2023 | Amount | Seed - AccurKardia | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AccurKardia
AccurKardia has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Banco Popular. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Commercial banking services are offered to individuals and businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AccurKardia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AccurKardia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Accurkardia Comparisons
Competitors of AccurKardia
AccurKardia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endotronix, Edwards Lifesciences, CoachCare, BioIntelliSense and Element Science, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| domain | founded_year | HQ Location |
Medical devices for structural heart disease are developed and provided.
|
|
| domain | founded_year | HQ Location |
Remote monitoring platform for tracking patient activity
|
|
| domain | founded_year | HQ Location |
Vital signs are monitored via a single-use patch and platform.
|
|
| domain | founded_year | HQ Location |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| domain | founded_year | HQ Location |
Contactless patient monitoring is provided for mental health facilities.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Accurkardia
Frequently Asked Questions about AccurKardia
When was AccurKardia founded?
AccurKardia was founded in 2019 and raised its 1st funding round 4 years after it was founded.
Where is AccurKardia located?
AccurKardia is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of AccurKardia?
Juan C Jimenez is the current CEO of AccurKardia. They have also founded this company.
Is AccurKardia a funded company?
AccurKardia is a funded company, having raised a total of $6.81M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2.7M, raised on Jun 20, 2023.
What does AccurKardia do?
AccurKardia was established in 2019 in New York, United States, as a medical AI software firm. Cloud-based solutions are offered for automated ECG interpretation at clinical grade. Real-time cardiac monitoring is facilitated in hospital settings via device-agnostic tools and API integration. Operations focus on enhancing cardiac care through connected systems in the healthcare sector.
Who are the top competitors of AccurKardia?
AccurKardia's top competitors include Endotronix, Oxehealth and BioIntelliSense.
What products or services does AccurKardia offer?
AccurKardia offers AccurECG, AK-AVS, and AK+ Guard.
Who are AccurKardia's investors?
AccurKardia has 1 investor. Key investors include Banco Popular.